Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Jim R. Schwartz"'
1
A successful model of biosimilar adoption in a community oncology practice
Autor: Lalan S. Wilfong, Jim R. Schwartz, Chris Sellers, Jody S. Garey, Sara Toth, Lance Ortega, Neal Dave, Barry Don Brooks
Publikováno v: Journal of Clinical Oncology. 39:6514-6514
6514 Background: The emergence of biosimilars creates an opportunity for more cost-effective treatment. Utilization of biologics in cancer care has increased and accounts for 70% of oncologic drug spending growth from 2010 to 2015. Biosimilars can pl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b4ae4b255bf229780d41c5f5397588d8
https://doi.org/10.1200/jco.2021.39.15_suppl.6514
Zobrazit plný text záznamu
2
Enhanced compliance with appropriate antiemetic prescribing guidelines by utilizing a medically integrated pharmacy antiemetic therapeutic interchange protocol
Autor: Debra A. Patt, Lalan S. Wilfong, Carla Portnoy, Jim R. Schwartz, Neal Dave, Sabrina Q. Mikan, Kathryn Wallace, J. Russell Hoverman
Publikováno v: Journal of Clinical Oncology. 36:55-55
55 Background: Appropriate antiemetic prescribing remains an unmet need in patients receiving emetogenic chemotherapy. Non-compliance with standard antiemetic guidelines is well reported, and a focus of the American Society of Clinical Oncology Choos
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c3c77f81a9b3f78af7b29bd56545a163
https://doi.org/10.1200/jco.2018.36.30_suppl.55
Zobrazit plný text záznamu
3
Medically integrated pharmacy: A team-based approach to improve oral oncolytic therapy for cancer patients
Autor: Kelani Condon, Holly Books, Margaret Harville, Lalan S. Wilfong, Chris Sellers, Jim R. Schwartz, Gurjyot K. Doshi, Neal Dave
Publikováno v: Journal of Clinical Oncology. 36:140-140
140 Background: The use of oral oncolytic therapies in the treatment of cancer is rising dramatically. Cost barriers to obtaining drugs and side effects of therapies lead 1 to poor adherence to oral regimens resulting in detrimental outcomes. Externa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::70eea4afeb32f9a3c125575ad9738b66
https://doi.org/10.1200/jco.2018.36.30_suppl.140
Zobrazit plný text záznamu
4
Efficacy of an antiemetic therapeutic interchange protocol driven by a medically integrated pharmacy
Autor: Carla Portnoy, Debra A. Patt, Leigh Kipley, Lalan S. Wilfong, J. Russell Hoverman, Jim R. Schwartz, Neal Dave, Kathryn Wallace, Sabrina Q. Mikan
Publikováno v: Journal of Clinical Oncology. 36:133-133
133 Background: Control of chemotherapy induced nausea and vomiting (CINV) remains an unmet need. An antiemetic therapeutic interchange protocol was developed to enhance control of CINV. This abstract reports the efficacy results of patients treated
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e2d077febd17eefc4f69810a157a2953
https://doi.org/10.1200/jco.2018.36.30_suppl.133
Zobrazit plný text záznamu
5
Scalp condition impacts hair growth and retention via oxidative stress
Autor: Jim R Schwartz, Ralph M. Trüeb, Michael G. Davis, James Patrick Henry
Publikováno v: International Journal of Trichology
Conventionally, the medical focus has been either on hair loss or the condition of the scalp in terms of specific dermatological diseases. Indeed, the proximate structural arrangement of the scalp and hair leads to an interdependent relationship betw
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81dfd8aa901a7c21c0e49934374fa8f2
https://doi.org/10.4103/ijt.ijt_57_18
Zobrazit plný text záznamu
6
Eleven-year experience with a web-based medication occurrence (MO) reporting tool in a community oncology practice
Autor: Jim R. Schwartz, J. Russell Hoverman, Tae W Jang
Publikováno v: Journal of Clinical Oncology. 34:53-53
53 Background: At ASCO 2007, we presented 2 year experience with a web-based Medication Occurrence (MO) reporting tool. We now report the 11 year experience in a single outpatient oncology practice. Methods: Since December 2003, Texas Oncology (TxO)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e48b7266c0bc6436e25b063b9594ed4a
https://doi.org/10.1200/jco.2016.34.7_suppl.53
Zobrazit plný text záznamu
7
11 Year Expereince with a Web-based Reporting Tool in a Community Outpatient Oncology Practice
Autor: Jim R. Schwartz, Tae W Jang, J. Russell Hoverman
Publikováno v: Journal of Clinical Oncology. 33:e17646-e17646
e17646 11 Year Experience with a Web-based Medication Reporting Tool in a Community Outpatient Oncology Practice Hoverman J, Jang T, Riegel G and Schwartz J Background: At ASCO 2007 we presented 2 year experience with a web-based medication occurrenc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::89f454b48859e62b056ab11f8814c3bd
https://doi.org/10.1200/jco.2015.33.15_suppl.e17646
Zobrazit plný text záznamu
8
The value of a quality metric
Autor: J. Russell Hoverman, Jim R. Schwartz
Publikováno v: Journal of Clinical Oncology. 30:239-239
239 Background: The value of a quality metric is tied to improving outcomes or reducing costs while maintaining outcomes. In the last year ASCO/ONS Chemotherapy Safety metric 1F has changed from requiring current BLS (Basic Life Support) certificatio
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2a51c54aef4ad0717120594650c4a834
https://doi.org/10.1200/jco.2012.30.34_suppl.239
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje